Hydrocodone cough suppressants will be taken off the market.

  The FDA will be pulling unapproved hydrocodone cough suppressants from the market.

  The withdrawal mostly concerns hydrocodone cough preps with guaifenesin (Hycotus, etc) or with homatropine PLUS an expectorant or decongestant (Histinex, etc).

  These drugs came on the market before proof of efficacy and safety was required. Some of the unapproved products are also inappropriately labeled for use in children as young as 2-years-old. Hydrocodone cough suppressants have not been proven safe or effective for children under 6-years-old.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote